Dive Into Dollar Tr...
Health Care: Drugs
Keryx Biopharmaceuticals Inc. (KERX: NASDAQ)
$8.04 0.04 | 0.50%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -22.72M | -28.12M | -20.33M | 10.48M |
| Operating Gains/Losses | 0.00 | 0.00 | 82.00K | -173.00K |
| Extraordinary Gains / Losses | 2.64M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 7.00K | -7.00K | 66.00K | -41.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 104.00K | -334.00K | 1.32M | -1.01M |
| (Decrease) Increase In Payables | -1.66M | 3.82M | 366.00K | 647.00K |
| (Decrease) Increase In Other Current Liabilities | -70.00K | 0.00 | -86.00K | 0.00 |
| (Increase) Decrease In Other Working Capital | 12.00K | -72.00K | -71.00K | -18.68M |
| Other Non-Cash Items | -3.11M | 1.85M | 2.38M | 3.17M |
| Net Cash From Continuing Operations | -24.76M | -22.82M | -16.21M | -5.52M |
| Net Cash From Discontinued Operations | 0.00 | 1.00K | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -24.76M | -22.82M | -16.21M | -5.52M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 15.48M | 5.83M | 35.81M | 2.34M |
| Purchases of Property, Plant & Equipment | -24.00K | -57.00K | -23.00K | -4.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -11.26M | -9.94M | -18.37M | -17.59M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 4.19M | -4.17M | 19.04M | -9.70M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | 33.83M | 9.19M | 18.46M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 0.00 | 33.83M | 9.19M | 18.46M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -20.58M | 6.84M | 12.03M | 3.24M |
Portfolios with KERX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserBio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- User1st Time out
Latest KERX Headlines from TheStreet
- Short Interest Increases 10% For KERX 05.10.13 | 04:05 pm
- Keryx Biopharmaceuticals Inc. (KERX): Today's Featured Health Care Winner 04.22.13 | 05:04 pm
- Today's Drugs Industry Featured Laggard: Keryx Biopharmaceuticals Inc. (KERX) 04.11.13 | 05:04 pm
- Bears Eat Herbalife, JC Penney - Bulls Find Keryx
04.09.13 | 12:04 pm - Keryx Biopharmaceuticals Inc. (KERX): Health Care's Highlighted Dud Of The Day 03.26.13 | 05:03 pm
- Keryx CEO vs. A Short Seller: Zerenex Patent Debate 03.13.13 | 07:03 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 03.08.13 | 07:03 pm
- Why Expect More Price Swings From These 4 Biotechs 02.28.13 | 11:02 am
- Keryx Biopharmaceuticals Inc. (KERX): Today's Featured Drugs Laggard 02.27.13 | 05:02 pm
- Keryx Biopharmaceuticals Inc. (KERX): Today's Featured Health Care Winner 02.12.13 | 05:02 pm
Press Releases for KERX
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Keryx Biopharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2013 To Seek A Lead Plaintiff Position - Business Wire 03.25.13 | 08:03 am
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Keryx Biopharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2013 To Seek A Lead Plaintiff Position - PR Newswire 03.19.13 | 06:03 pm
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Keryx Biopharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2013 To Seek A Lead Plaintiff Position - Business Wire 03.18.13 | 05:03 pm
- Keryx Biopharmaceuticals To Present At The 25th Annual ROTH Conference - PR Newswire 03.14.13 | 08:03 am
- Keryx Biopharmaceuticals Announces Appointment Of Amit Sharma, M.D. As Vice President, Medical Affairs - PR Newswire 03.13.13 | 08:03 am
- Keryx Biopharmaceuticals, Inc. To Host Conference Call On Fourth Quarter And Year-End 2012 Financial Results - PR Newswire 03.11.13 | 08:03 am
- Keryx Biopharmaceuticals To Present At The Citigroup 2013 Global Healthcare Conference - PR Newswire 02.22.13 | 08:02 am
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact The Firm - PR Newswire 02.08.13 | 09:02 pm
- Harwood Feffer LLP Announces Investigation Of Keryx Biopharmaceuticals, Inc. - PR Newswire 02.08.13 | 12:02 pm
- Keryx Biopharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference Presentation Scheduled For Monday, February 11th At 2:30 PM ET - PR Newswire 02.08.13 | 08:02 am
Partner Headlines for KERX
- Zerenex Phase III Data Imminent; Odds Still High For Keryx To Succeed With This Drug - Seeking Alpha 01.22.13 | 09:01 am
- Dawson James Securities Reiterates Market Outperform Rating, $4 PT on Keryx Biopharmaceuticals - Benzinga 11.28.12 | 09:11 am
- Healthcare Biz Roundup: Keryx Jumps Without CAUSE, Teva Not A MONOPOLIST - Wall St. Cheat Sheet 07.04.12 | 08:07 am
- Zacks' Voice of the People highlights opportunities with Starbucks, Realty Income, Keryx Biopharma, Bon-Ton Stores and Orexigen Therapeutics - Press Releases - Zacks 04.12.12 | 09:04 am
- 2 Biotech Stocks To Consider Now, 1 To Avoid - Seeking Alpha 04.10.12 | 09:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.16.12 | 05:03 pm
- Morning Social Media Outlook for Tuesday Mar 6 (SHFL, HAR, PCX, NTRI) - Benzinga 03.06.12 | 09:03 am
- FDA Approval Practically A Done Deal For Keryx And AEterna Zentaris - Seeking Alpha 03.02.12 | 05:03 pm
- 3 Boring Dividend Stocks You Will Grow To Love - Seeking Alpha 02.26.12 | 07:02 am
